Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Immunohistochemical expression of hormone receptors, Ki-67, endoglin (CD105), claudins 3 and 4, MMP-2 and-9 in endometrial polyps and endometrial cancer type I

Full text
Author(s):
Peres, Gustavo Filipov [1] ; Spadoto-Dias, Daniel [1] ; Bueloni-Dias, Flavia Neves [1] ; Leite, Nilton Jose [1] ; Elias, Leonardo Vieira [1] ; Custodio Domingues, Maria Aparecida [2] ; Padovani, Carlos Roberto [3] ; Dias, Rogerio [1]
Total Authors: 8
Affiliation:
[1] Sao Paulo State Univ, Dept Gynecol & Obstet, Inst Biosci, Botucatu Med Sch, Botucatu, SP - Brazil
[2] Sao Paulo State Univ, Dept Clin Pathol, Inst Biosci, Botucatu Med Sch, Botucatu, SP - Brazil
[3] Sao Paulo State Univ, Dept Biostat, Inst Biosci, Botucatu Med Sch, Botucatu, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: ONCOTARGETS AND THERAPY; v. 11, p. 3949-3958, 2018.
Web of Science Citations: 0
Abstract

Objective: The aim of this study was to investigate the malignant potential of endometrial polyps (EP) by assessing the immunoexpressions of both estrogen receptor (ER) and progesterone receptor (PR), Ki-67 cell proliferation index, neovascularization network (endoglin - CD105), cellular adhesion molecules (claudins 3 and 4), and extracellular matrix proteins (MMP-2 and -9) in both EP and endometrioid adenocarcinoma (type I) in comparison with the normal endometrium. Study design: This is a cross-sectional comparative study. Patients were identified from the database of Botucatu Medical School, Sao Paulo State University (BMS-UNESP) Clinical Pathology Laboratory. Setting: The study was conducted using a convenience sample of patients attending the Sectors of Gynecologic Endoscopy and Family Planning and Gynecologic Oncology of the Department of Gynecology and Obstetrics of BMS-UN ESP, Brazil. Patients: A total of 90 women were allocated into the following three groups: EP without atypic (EP, n=30), endometrioid endometrial cancer (EC, n=30), and normal endometrium (control, n=30). Methods: Epidemiological and clinical data were obtained by reviewing medical records. Adenocarcinoma and control cases were assessed using the tissue microarray technique. The immunoexpressions of ER, PR, Ki-67, CD105, claudins 3 and 4, and MMP-2 and -9 were assessed in paraffin blocks containing sections of the largest polyploid lesion fragment and tissue microarray recipient blocks. Major results: Compared to the control group, significant differences in the expression of ER (P<0.001), PR (P<0.05), Ki-67 (P<0.001), C D105 (P<0.001), and claudin 3 (P <0.001) were observed in EP and EC. No significant differences were found between EP and EC (P >= 0.05). M M P-2 and -9 expression were nearly absent in all groups. Conclusion: The malignant potential of EP could not be determined through the immunohistochemical parameters used in this study. No MMP-2 or -9 expression was observed in any endometrial tissue sample. Further studies are necessary for a better understanding of the biomolecular mechanisms underlying endometrial carcinogenesis. (AU)

FAPESP's process: 12/17297-3 - Investigation of the development of endometrial polyps in endometrial cancer
Grantee:Rogério Dias
Support type: Regular Research Grants